Clinical Trial

Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage

Study acronym: NOVIC
Recruiting
View on ClinicalTrials.gov →
Summary
This will be the first, definitive, randomized control trial (N=424) to test the hypothesis that the Jada® System is effective, safe and cost-effective in treating PPH, compared to standard care.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-05-15; most recent amendment 2023-12-14.
Status change: Not Yet Recruiting → Recruiting 2023-12-14
Trial Details
NCT Number NCT05382403
Lead Sponsor Women and Infants Hospital of Rhode Island
Collaborators: Washington University School of Medicine, University of Ghana, Kwame Nkrumah University of Science and Technology
Conditions Postpartum Hemorrhage, Maternal Death
Enrollment 424 participants
Start Date 2023-10-23
Primary Completion 2026-08-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2023-12-21